EUVIMEDEUVIMED entdecken
Multizentrische Studie

Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia

Maria Eva Mingot-Castellano iD, Jose Maria Bastida, Waleed Ghanima, Elena Ruiz Sainz, Ramiro Nuñez Vazquez, Begoña Pedrote Amador, Laila Abdel-Kader Martín, Dolores Piquer-Monsonis, Mariana Canaro

British Journal of Haematology · 2024-10 · 205 (4) · 1551-1555

DOI: 10.1111/bjh.19602 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Haematology, online erschienen am 19.06.2024. Verfasst von Maria Eva Mingot-Castellano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS /CSIC), Universidad de Sevilla, Sevilla, Sp…. Hauptthemen laut MEDLINE: Drug Therapy, Combination, Morpholines, Purpura, Thrombocytopenic, Idiopathic, Thiazoles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune thrombocytopenia (ITP) refractory to multiple therapies may require a combination of drugs targeting different mechanisms and targets. In this retrospective, multicentre, international study, we report the safety and effectiveness of avatrombopag and fostamatininb in combination administered to 18 patients with multirefractory ITP. Overall, the combination response was achieved in 15 patients (83.3%), with a median time from combination start to best response of 15 days (IQR: 8–35 days). After a median follow‐up of 256 days (IQR: 142.8–319), 5 patients relapsed (26.7%), all during tapering or stopping one drug. Adverse events were described in 6 of 18 patients (33%).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Therapy, CombinationMorpholinesPurpura, Thrombocytopenic, IdiopathicThiazolesAdultAgedFemaleHumansMaleMiddle AgedAminopyridinesHydrazinesOxazinesPyrazolesPyridinesPyrimidinesRetrospective StudiesThiophenesTreatment Outcome

Stichwörter der Autor:innen

ITPSYK inhibitorTPO‐RAcombining treatment

Substanzen

AminopyridinesavatrombopagfostamatinibHydrazinesMorpholinesOxazinesPyrazolesPyridinesPyrimidinesThiophenes

Autor:innen und Institutionen

  • Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS /CSIC), Universidad de Sevilla, Sevilla, Spain.
  • Hematology Department, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca (USAL), Salamanca, Spain.
  • Department of Research and Haemato-Oncology, Østfold Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hematology Department, Hospital del Tajo, Aranjuez, Madrid, Spain.
  • Pharmacy Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
  • Hematology Department, Hospital Son Espases, Mallorca, Spain.

ORCID-Profile: Maria Eva Mingot-Castellano

Zitieren

APA

Mingot-Castellano, M. E., Bastida, J. M., Ghanima, W., Ruiz Sainz, E., Nuñez Vazquez, R., Pedrote Amador, B., Abdel-Kader Martín, L., Piquer-Monsonis, D., & Canaro, M. (2024). Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia. British Journal of Haematology, 205(4), 1551-1555. https://doi.org/10.1111/bjh.19602

Vancouver

Mingot-Castellano ME, Bastida JM, Ghanima W, Ruiz Sainz E, Nuñez Vazquez R, Pedrote Amador B, et al. Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia. British Journal of Haematology. 2024;205(4):1551-1555. doi:10.1111/bjh.19602

BibTeX
@article{MingotCastellano2024,
  author = {Mingot-Castellano, Maria Eva and Bastida, Jose Maria and Ghanima, Waleed and Ruiz Sainz, Elena and Nuñez Vazquez, Ramiro and Pedrote Amador, Begoña and Abdel-Kader Martín, Laila and Piquer-Monsonis, Dolores and Canaro, Mariana},
  title = {Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia},
  journal = {British Journal of Haematology},
  year = {2024},
  volume = {205},
  number = {4},
  pages = {1551--1555},
  doi = {10.1111/bjh.19602}
}
Kostenlos starten →